- •Ultrasonographic prevalence of lipohypertrophy was 58%.
- •Incorrect rotation of injection sites and reuse of needles predicted the development of lipohypertrophy.
- •Ultrasonography is a more objective method for early detection of lipohypertrophy.
- •Clinical and ultrasonographic characterstics of patients with insulin derived amyloidosis were almost similar to lipohypertrophy.
- •Insulin derived amyloidosis may be a more common complication of insulin therapy than previously thought.
- New injection recommendations for patients with diabetes.Diabetes Metab. 2010; 36: S3-18
- Results and analysis of the 2008–2009 Insulin Injection Technique Questionnaire survey.J. Diabetes. 2010; 2: 168-179
- Skin-related complications of insulin therapy: epidemiology and emerging management strategies.Am. J. Clin. Dermatol. 2003; 4: 661-667
- Cutaneous manifestations of diabetes mellitus in children.Pediatr. Dermatol. 1985; 2: 161-179
- Systematic inspection of insulin injection sites for local complications related to incorrect injection technique.Trop. Doct. 1996; 26: 159-161
- Lypohypertrophy in patients receiving insulin therapy: state of the art.Diabetes Mellitus. 2011; 14: 80-83
- Iatrogenic, insulin-dependent, local amyloidosis.Lab. Invest. 1983; 48: 108-111
- Localized insulin-derived amyloidosis in patients with diabetes mellitus: a case report.Hum. Pathol. 2009; 40: 1655-1660
- Lipohypertrophy in young patients with type 1 diabetes.Diabetes Care. 2002; 25: 634
- Prevalence of lipohypertrophy in insulin-treated diabetes patients: a systematic review and meta-analysis.J. Diabetes Invest. 2017; 9: 536-543https://doi.org/10.1111/jdi.12742
- Clinical implications of lipohypertrophy among people with type 1 diabetes in India.Diabetes Technol. Ther. 2018; 20 (483–49)
- Ultrasonography of insulin injection sites in diabetic patients: a new method of lipohypertrophy diagnostics. Endocrine reviews.in: Drucker Daniel Conference: 95th annual meeting and expo of the Endocrine Society, ENDO, 34, Supplement 1. Oxford Academic, 2013: i1306 (34 (Suppl. 1))
- Ultrasonographic aspect of subcutaneous tissue dystrophies as a result of insulin injections.Med Ultrasonogr. 2010; 12: 104-109
- A suitable palpation technique allows to identify skin lipohypertrophic lesions in insulin-treated people with diabetes.Springerplus. 2016; 5 (PMID: 27213130; PMCID: PMC4859222): 563https://doi.org/10.1186/s40064-016-1978-y
- Prevalence and risk factors of lipohypertrophy in insulin-injecting patients with diabetes.Diabetes Metab. 2013; 39: 445-453
- Lipohypertrophy in children and adolescents with type 1 diabetes and the associated factors.BMC Res. Notes. 2011; 4: 290
- Nodules of fibro-collagenous scar tissue induced by subcutaneous insulin injections: a cause of poor diabetic control.Postgrad. Med. J. 2004; 80: 732-733
- Factors related to lipohypertrophy in insulin-treated diabetic patients: role of educational intervention.Pract. Diabetes Int. 1998; 15: 9-11
- Poor glycemic control caused by insulin lipohypertrophy.BMJ. 2003; 327: 383-384
- Incidence of lipohypertrophy in diabetic patients and a study of influencing factors.Diabetes Res. Clin. Pract. 2007; 77: 231-236
- Lipohypertrophy in individuals with type 2 diabetes: prevalence and risk factors.J. Caring Sci. 2018; 7: 67-74
- Insulin-derived amyloidosis and poor glycemic control: a case series.Am. J. Med. 2014; 127: 450-454
☆Presentation at meeting: Presented abstract in ADA 2020.